BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2881296)

  • 1. Gene expression of gonadotropin-releasing hormone and its receptor in rat pancreatic cancer cell lines.
    Wang L; Xie LP; Zhang RQ
    Endocrine; 2001 Apr; 14(3):325-8. PubMed ID: 11444428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: a review of emerging therapies.
    Rosenberg L
    Drugs; 2000 May; 59(5):1071-89. PubMed ID: 10852640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.
    Fisher WE; Muscarella P; Boros LG; Schirmer WJ
    Int J Pancreatol; 1998 Dec; 24(3):169-80. PubMed ID: 9873951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.
    Rosenberg L
    Int J Pancreatol; 1997 Oct; 22(2):81-93. PubMed ID: 9387029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-signaling targets for antitumour drug development.
    Brunton VG; Workman P
    Cancer Chemother Pharmacol; 1993; 32(1):1-19. PubMed ID: 8384936
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.
    Perilli D; Mansi C; Savarino V; Celle G
    Int J Pancreatol; 1993 Jun; 13(3):159-68. PubMed ID: 8103783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations.
    Mason-Garcia M; Vaccarella M; Horvath J; Redding TW; Groot K; Orsolini P; Schally AV
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5688-92. PubMed ID: 2899894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.
    Wiedenmann B; Räth U; Rädsch R; Becker F; Kommerell B
    Klin Wochenschr; 1988 Jan; 66(2):75-7. PubMed ID: 2894481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen influence on exocrine pancreatic cancer.
    Andrén-Sandberg A
    Int J Pancreatol; 1989 May; 4(4):363-9. PubMed ID: 2659684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa).
    Edwards BF; Redding TW; Schally AV
    Int J Pancreatol; 1989 Sep; 5(2):191-201. PubMed ID: 2600453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
    Zalatnai A; Schally AV
    Int J Pancreatol; 1989 Mar; 4(2):149-60. PubMed ID: 2566638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
    Szende B; Zalatnai A; Schally AV
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.
    Banks WA; Schally AV; Barrera CM; Fasold MB; Durham DA; Csernus VJ; Groot K; Kastin AJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6762-6. PubMed ID: 1975697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of pancreatic cancer.
    Poston GJ; Gillespie J; Guillou PJ
    Gut; 1991 Jul; 32(7):800-12. PubMed ID: 1855689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells.
    Szende B; Srkalovic G; Timar J; Mulchahey JJ; Neill JD; Lapis K; Csikos A; Szepeshazi K; Schally AV
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4153-6. PubMed ID: 1851995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines.
    Takeda Y; Escribano MJ
    J Cancer Res Clin Oncol; 1991; 117(5):416-20. PubMed ID: 1679759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of orchiectomy, alone or in combination with testosterone, and cyproterone acetate on exocrine pancreatic carcinogenesis in rats and hamsters.
    Meijers M; Visser CJ; Klijn JG; Lamberts SW; van Garderen-Hoetmer A; de Jong FH; Foekens JA; Woutersen RA
    Int J Pancreatol; 1992 Apr; 11(2):137-46. PubMed ID: 1535094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
    Paz-Bouza JI; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1112-6. PubMed ID: 2881296
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.